Saturday, July 11, 2026

pharma · Advanced Solid Tumor

LaNova Medicines

LaNova Medicines clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Shanghai, CN HQ
2019 Founded
15 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Shanghai, CN
Founded
2019
Employees
15
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

LaNova Medicines projects

1 ClinicalTrials.gov programs sponsored by LaNova Medicines.

LaNova Medicines has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. LM-302

    LaNova Medicines Limited

    Advanced Solid Tumor

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does LaNova Medicines have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.